MassHealth GLP-1 Coverage Debate: At a Beacon Hill briefing, Martin Luther King III warned that MassHealth’s move to stop covering GLP-1 weight-loss drugs could deepen health inequities, arguing the medications treat obesity-related comorbidities and may save lives. Health Equity & Insurance Costs: The same coverage shift is also being criticized as raising equity issues across state programs and commercial plans, as Massachusetts grapples with rising healthcare costs and premium pressure. New Clinical Research in Optic Disease: Life Biosciences will present interim Phase 1 ER-100 data for optic neuropathies at AAO Eyecelerator, aiming to restore retinal ganglion cells rather than just slow decline. Cancer Trial Pipeline Expands: Aktis Oncology launched a Phase 1b BActinium-2 trial of AKY-2519 for B7-H3 expressing tumors, following its earlier prostate cancer study. Drug Pricing Accountability: Michigan AG Dana Nessel urged consumers to file claims tied to multistate settlements over alleged generic drug price-fixing, with preliminary court approval for a consumer distribution plan. Public Health Awareness: The Facial Pain Association marked Facial Pain Awareness Month, highlighting trigeminal neuralgia and other neuropathic facial pain disorders and calling for better diagnosis and care.